MUSEUM NAT DHISTOIRE NATURELLE has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in France, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, measurement and environmental technology are INST OF NUCLEAR ENERGY RES ROC, JIANGXI QIANLONG PHARMACEUTICAL CO LTD and WORLD TRADE IMP EXPORT WTIE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Environmental technology | |
#4 | Basic materials chemistry | |
#5 | Furniture and games |
# | Name | Total Patents |
---|---|---|
#1 | Rebuffat Sylvie | 7 |
#2 | Lejeune Fabrice | 7 |
#3 | Maulay-Bailly Christine | 7 |
#4 | Amand Séverine | 4 |
#5 | Amand Severine | 3 |
#6 | Llamosi Artémis | 2 |
#7 | Toussaint Séverine | 2 |
#8 | Riffet Xavier | 1 |
#9 | Toussaint Severine | 1 |
#10 | Llamosi Artemis | 1 |
Publication | Filing date | Title |
---|---|---|
US2019240228A1 | Purine derivative for use in the treatment or prevention of diseases caused by a nonsense mutation | |
WO2018073414A1 | Lepista flaccida intended to be used for treating a disease caused by a nonsense mutation | |
EP3335021A1 | Force sensor | |
AU2012257453A1 | Composter to be vertically attached |